Royalty Pharma RPRX
NASDAQ RPRX
$58.22 -0.15 (-0.26%)
At close: Sep 29, 2026 · 4:00 PM EDT

Royalty Pharma (RPRX) Non Operating Interest Expenses (2019 - 2026)

Updated

Royalty Pharma (RPRX) posted Non Operating Interest Expenses of $93.62 million for Q2 2026, up 36.3% from $68.67 million a year earlier but down 0.1% from the prior quarter.

Analysis

Royalty Pharma (RPRX) Non Operating Interest Expenses (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Royalty Pharma was $361.07 million, up 35.6% year-over-year; for FY2025, it came in at $307.66 million, up 36.4% from FY2024.

  • Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of 14.4% (FY2020 to FY2025).
  • In prior years, Royalty Pharma's Non Operating Interest Expenses was $225.51 million in FY2024 (+20.5%), $187.19 million in FY2023 (-0.4%), $187.96 million in FY2022 (+13.1%) and $166.14 million in FY2021 (+5.8%).
  • Quarterly Non Operating Interest Expenses has run from a low of $44.23 million in Q1 2024 to a high of $94.17 million in Q4 2025 over five years.
  • On a year-over-year basis, Non Operating Interest Expenses has increased in each of the last nine quarters, with growth averaging 39.3% over the last eight quarters.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q1 2025, with growth of 47.5%; the weakest was Q1 2024, with a decline of 5.8%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $93.72 million (Q1 2026), $94.17 million (Q4 2025) and $79.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Orix 43.85 Bn 44.35 Bn - 281.69 Mn
2 Rocket Companies 43.67 Bn 29.35 Bn - 374.00 Mn
3 Royalty Pharma 33.56 Bn 33.48 Bn - 93.62 Mn
4 Federal National Mortgage Association Fannie Mae 25.52 Bn 25.52 Bn - -
5 Synchrony Financial 23.24 Bn -44.73 Bn - -
6 Affirm Holdings 22.66 Bn 16.35 Bn - 118.51 Mn
7 Royal Gold 20.35 Bn 19.57 Bn 390.45 Mn 10.01 Mn
8 Annaly Capital Management 15.27 Bn 6.37 Bn - 1.32 Bn
9 Ares Capital 13.74 Bn 11.17 Bn - 214.00 Mn
10 Federal Home Loan Mortgage 12.68 Bn -6.06 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 93.62 Mn
Mar 31, 2026 93.72 Mn
Dec 31, 2025 94.17 Mn
Sep 30, 2025 79.56 Mn
Jun 30, 2025 68.67 Mn
Mar 31, 2025 65.26 Mn
Dec 31, 2024 65.76 Mn
Sep 30, 2024 66.51 Mn
Jun 30, 2024 49.01 Mn
Mar 31, 2024 44.23 Mn
Dec 31, 2023 47.26 Mn
Sep 30, 2023 46.03 Mn
Jun 30, 2023 46.95 Mn
Mar 31, 2023 46.95 Mn
Dec 31, 2022 46.96 Mn
Sep 30, 2022 46.98 Mn
Jun 30, 2022 46.97 Mn
Mar 31, 2022 47.06 Mn
Dec 31, 2021 46.97 Mn
Sep 30, 2021 44.33 Mn
API Access

Royalty Pharma Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RPRX&period=max&api_key=YOUR_API_KEY